Efficacy and tolerability of levetiracetam treatment in an epileptic patient with SLE.
Siniscalchi
Antonio
A
Mancuso
Franco
F
Gallelli
Luca
L
Luca
Gallelli
G
Ferreri
Guido Ibbadu
GI
Ibbadu
Guido Ferreri
GF
Giovambattista
De Sarro
DS
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use; D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use*; D004347:Drug Interactions; D017029:Epilepsy, Complex Partial / Q000150:complications* / Q000188:drug therapy*; D005260:Female; D006801:Humans; D000077287:Levetiracetam; D008180:Lupus Erythematosus, Systemic / Q000150:complications*; D010889:Piracetam / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011241:Prednisone / Q000009:adverse effects / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D000927:Anticonvulsants; D000077287:Levetiracetam; D011241:Prednisone; D010889:Piracetam